Dr. Lal Pathlabs Share Price
Small Cap | Pharmaceuticals and health care | NSE: LALPATHLAB | BSE: 539524
₹2,601.00 -25.75 (-0.98 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 2,626.00
High (₹) 2,626.00
Low (₹) 2,548.05
Prev. Close (₹) 2,626.75
Volume 2,337
VWAP (₹) 2,585.53
ROCE (%) 26.86
Industry P/E 90.16
TTM P/E 52.17
P/B Ratio 11.51
Market Cap (₹) Cr.21,729.67
Dividend Yield (%)0.92
EPS (₹) 42.98
ROE19.03%
Sales Growth (%) 10.4
Profit Growth (%)50.28
Day Range
2,626.002,626.00
52 Week Range
1,943.203,645.00
Historical Returns
Returns (6M)
-21.64 %
Returns (1Y)
6.32 %
Returns (3Y)
-2.71 %
Returns (5Y)
58.85 %
Returns (6M)
-21.64 %
Returns (1Y)
6.32 %
Returns (3Y)
-2.71 %
Returns (5Y)
58.85 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (49.55%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 49.55% positive TTM EPS growth
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 26.01
MFI 20.35
ATR 63.18
Commodity Channel Index -103.20
ROC125 -21.41
ROC21 -8.13
Williams %R -84.19
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 2,633.05 | 2,668.50 | 2,711.00 | 2,590.55 | 2,555.10 | 2,512.60 | 2,477.15 |
Week Ago | 2,645.31 | 2,670.53 | 2,700.31 | 2,615.53 | 2,590.31 | 2,560.53 | 2,535.31 |
Month Ago | 2,833.34 | 2,872.32 | 2,899.19 | 2,806.47 | 2,767.49 | 2,740.62 | 2,701.64 |
EMA & SMA
2601.00
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 2620.61
9 Day 2650.26
10 Day 2672.03
12 Day 2699.54
14 Day 2712.55
20 Day 2724.16
26 Day 2754.89
50 Day 2856.03
100 Day 3016.55
200 Day 2989.87
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 25 Oct, 2022 | ₹2,550.90 | 12,949 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹2,550.90 | 69,319 | BSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 25 Oct, 2022 | ₹2,550.90 | 12,949 | BSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹2,550.90 | 69,319 | BSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 17 Oct, 2022 | ₹2,377.50 | 12,934 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹2,377.50 | 69,250 | BSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 17 Oct, 2022 | ₹2,377.50 | 12,934 | BSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹2,377.50 | 69,250 | BSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11 Oct, 2022 | ₹2,374.50 | 8,419 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹2,374.50 | 45,074 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
19 Feb, 2025 | Rahul Sharma | Acquisition | ₹311.30 | 4,000 | BSE |
19 Feb, 2025 | Shankha Banerjee | Acquisition | ₹10.00 | 1,000 | BSE |
19 Feb, 2025 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹218.1675824175824175824175824 | 2,184 | BSE |
12 Feb, 2025 | Om Prakash Manchanda | Disposal | ₹2,730.185758513931888544891641 | 10,336 | BSE |
05 Feb, 2025 | Nimish Jindal | Acquisition | ₹10.00 | 675 | BSE |
05 Feb, 2025 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹10.00 | 2,646 | BSE |
02 Jan, 2025 | SALONI KHERA | Acquisition | ₹10.00 | 400 | BSE |
02 Jan, 2025 | Rahul Sharma | Disposal | ₹2,960.1922 | 5,000 | BSE |
31 Dec, 2024 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹10.00 | 800 | BSE |
27 Dec, 2024 | Dr. Lal PathLabs Employee Welfare Trust | Disposal | ₹517.9502645502645502645502646 | 945 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
30 Jan, 2025 | Rs.6.0000 per share(60%)Third Interim Dividend | 05 Feb, 2025 | 05 Feb, 2025 |
23 Oct, 2024 | Rs.6.0000 per share(60%)Second Interim Dividend | 05 Nov, 2024 | 05 Nov, 2024 |
07 Aug, 2024 | Rs.6.0000 per share(60%)Interim Dividend | 20 Aug, 2024 | 20 Aug, 2024 |
Announcements
Date | Source | Detail |
---|---|---|
18 Feb, 2025 | NSE India | DR. LAL PATH LABS LTD. has informed the Exchange regarding Allotment of Securities |
18 Feb, 2025 | BSE India | Intimation for allotment of Equity Shares under ESOP Plan 2010 |
18 Feb, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Allotment of 4000 Shares. |
08 Feb, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication |
07 Feb, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot |
07 Feb, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Notice of Postal Ballot |
06 Feb, 2025 | NSE India | Dr. Lal Path Labs Ltd. has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |
06 Feb, 2025 | BSE India | Attached |
06 Feb, 2025 | NSE India | Update on Voluntary Liquidation of Suburban Diagnostics (India) Private Limited, Wholly Owned Subsidiary |
03 Feb, 2025 | BSE India | Attached |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results, Dividend & Others | To consider other business matters. | 24 Jan, 2025 | 30 Jan, 2025 |
Quarterly Results & Interim Dividend | -- | 17 Oct, 2024 | 23 Oct, 2024 |
Quarterly Results & Interim Dividend | -- | 01 Aug, 2024 | 07 Aug, 2024 |
Audited Results & Final Dividend | -- | 07 May, 2024 | 10 May, 2024 |
Quarterly Results & Interim Dividend | -- | 30 Jan, 2024 | 01 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 02 Nov, 2023 |
Quarterly Results & Interim Dividend | -- | 21 Jul, 2023 | 27 Jul, 2023 |
Audited Results & Final Dividend | -- | 04 May, 2023 | 11 May, 2023 |
Quarterly Results | -- | 25 Jan, 2023 | 02 Feb, 2023 |
Quarterly Results | -- | 02 Nov, 2022 | 08 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Dr. Lal Pathlabs
Dr. Lal Pathlabs is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1966.76 Cr. and Equity Capital is Rs. 83.48 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Dr. Om Prakash Manchanda
NSE Symbol
LALPATHLAB
Dr. Lal Pathlabs Management
Name | Designation |
---|---|
Brig.(Hony) Dr. Arvind Lal | Executive Chairman |
Dr. Om Prakash Manchanda | Managing Director |
Dr. Vandana Lal | Whole Time Director |
Mr. Rahul Sharma | Non Executive Director |
Dr. Archana Lal Erdmann | Non Executive Director |
Mr. Gurinder Singh Kalra | Independent Director |
Mr. Rajit Mehta | Independent Director |
Mrs. Somya Satsangi | Independent Director |
Mr. Rohit Bhasin | Independent Director |
Mr. Arun Duggal | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Max Heal.Ins | ₹1,09,500.95 | ₹1,010.25 ₹1,031.85(-2.09%) | ₹669.650 - ₹1,215.000 |
Apollo Hspt | ₹1,04,190.68 | ₹6,317.55 ₹6,390.95(-1.15%) | ₹5,639.700 - ₹7,545.100 |
Fortis Healt | ₹51,495.70 | ₹619.35 ₹609.90(1.55%) | ₹375.100 - ₹740.100 |
GlobalHealth | ₹29,286.77 | ₹1,235.55 ₹1,206.40(2.42%) | ₹930.000 - ₹1,513.750 |
Narayana Hru | ₹26,515.81 | ₹1,396.80 ₹1,404.55(-0.55%) | ₹1,087.800 - ₹1,445.050 |
FAQs on Dr. Lal Pathlabs
What is the share price of Dr. Lal Pathlabs?
The share price of Dr. Lal Pathlabs on 21 Feb, 2025 is ₹ 2,601.00.
What is 52W high and 52W low share price of Dr. Lal Pathlabs?
The highest and lowest 52W share prices of Dr. Lal Pathlabs are ₹ 3645.000 and ₹ 1943.200
What is the market cap of Dr. Lal Pathlabs?
The market capitalization of Dr. Lal Pathlabs as of 21 Feb, 2025 is ₹ 21,729.67 Crores
What is the P/E ratio of Dr. Lal Pathlabs?
The current P/E ratio of Dr. Lal Pathlabs as of 21 Feb, 2025 is 90.16
What is the PB ratio of Dr. Lal Pathlabs?
The PB ratio of Dr. Lal Pathlabs as of 21 Feb, 2025 is 11.51
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)